Global intensive food industry by 2030

DUBLIN, September 23, 2021 / PRNewswire / – The report, “Critical Care Nutrition Market by Route of Administration, Application, and Age Group: Global Opportunity Analysis, and Industry Forecast 2021-2030” has been added to the offering from ResearchAndMarkets.com.

The global critical care food market was rated with $ 10,618.96 million in 2020 and is expected to be achieved $ 19,237.81 million by 2030 with a CAGR of 6.1% from 2021 to 2030.

Intensive nutrition is referred to as nutritional support therapy for critically ill patients to achieve positive patient outcomes. In addition, critical care medicine is known to be providing safe and optimal nutrition that must be provided to patients entering the intensive care unit with evidence-based practice. This therapy is prescribed to patients with chronic conditions such as malnutrition, gastrointestinal diseases, and cancer. In addition, when taken in the early stages, nutritional therapy can help lessen the severity of the condition and reduce complications caused by inadequate nutrition. In addition, a reduction in the length of stay in the intensive care unit and a reduction in the death rate in patients who underwent early nutritional therapy would help the market generate higher revenues over the forecast period.

The increase in the prevalence of chronic conditions such as cancer and neurological disorders is the main factor contributing to the growth of the critical care nutrition market. According to 2020 statistics from the American Society of Clinical Oncology Journal, the cancer incidence rate in women is about 712,758, higher than that of men, which is about 679,421 for 2020. The projected national cancer incidence rate in 2020 was 98.7 per 100,000 population, that is around 1,392,179 patients as a conservative estimate. In addition, an increase in healthcare spending is expected to contribute significantly to market growth.

According to United Nations statistics in 2020, around 727 million people around the world are 65 years of age and older. That number is estimated at 1.5 billion by 2050. Hence, a huge increase in the geriatric population, the most susceptible to chronic disease and who require intensive nutrition to control the disease, is expected to fuel market growth. However, the lack of awareness of the nutrition of ICU patients admitted to ICU in underdeveloped countries will hold back market growth.

In addition, the development of newer technologically advanced products and increased market potential in untapped emerging countries are expected to offer lucrative opportunities for market growth.

Main advantages

  • The study provides an in-depth analysis of the market as well as current trends and future assessments to uncover the investment pockets ahead.
  • It offers a quantitative analysis from 2020 to 2030, which is intended to enable stakeholders to take advantage of the prevailing market opportunities.
  • A comprehensive analysis of the factors driving and stunting the growth of the market is provided.
  • The profiles and growth strategies of the major players are thoroughly analyzed to understand the competitive outlook of the market.

Key topics covered:

CHAPTER 1 INTRODUCTION

CHAPTER 2: SUMMARY

CHAPTER 3: MARKET LANDSCAPE
3.1. Market definition and scope
3.2. Main results
3.2.1. Top investment bags
3.2.2. Top winning strategies
3.3. Porter’s Five Forces Analysis
3.4. Top player positioning, 2020
3.5. Market dynamics
3.5.1. driver
3.5.1.1. Increase in health care expenditure for the patient population
3.5.1.2. Increase in the prevalence of age-related diseases
3.5.1.3. Increase in the incidence of the targeted disease
3.5.1.4. Benefits of intensive nutrition
3.5.2. Restrictions
3.5.2.1. Inadequate nutritional efficiency in critically ill patients
3.5.3. occasion
3.5.3.1. High market potential in emerging countries
3.5.4. Impact analysis
3.6. COVID-19 Impact Analysis on Intensive Care Nutrition Market

CHAPTER 4: NUTRITIONAL MARKET FOR CRITICAL CARE, BY ROUTE OF APPLICATION
4.1. overview
4.1.1. Market size and forecast
4.2. Enteral
4.2.1. Important market trends, growth factors and opportunities
4.2.2. Market size and forecast
4.2.3. Market analysis by country
4.3. Parenterals
4.3.1. Important market trends, growth factors and opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis by country

CHAPTER 5: NUTRITIONAL MARKET FOR CRITICAL CARE, BY APPLICATION
5.1. overview
5.1.1. Market size and forecast
5.2. cancer
5.2.1. Market size and forecast by region
5.2.2. Market analysis by country
5.3. Neurological diseases
5.3.1. Market size and forecast by region
5.3.2. Market analysis by country
5.3.3. Gastrointestinal disorders
5.3.4. Market size and forecast by region
5.3.5. Market analysis by country
5.4. Other
5.4.1. Market size and forecast by region
5.4.2. Market analysis by country

CHAPTER 6: FOOD MARKET FOR CRITICAL CARE, BY AGE GROUPS
6.1. overview
6.1.1. Market size and forecast
6.2. Pediatrics
6.2.1. Market size and forecast by region
6.2.2. Market analysis by country
6.2.3. Market Size and Forecast by Route of Administration
6.3. adult
6.3.1. Market size and forecast by region
6.3.2. Market analysis by country
6.3.3. Market Size and Forecast by Route of Administration
6.4. geriatrics
6.4.1. Market size and forecast by region
6.4.2. Market analysis by country
6.4.3. Market Size and Forecast by Route of Administration

CHAPTER 7: FOOD MARKET FOR CRITICAL CARE, BY REGION

CHAPTER 8: COMPANY PROFILES
8.1. ABBOTT LABORATORIES
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operational business areas
8.1.4. Product portfolio
8.1.5. Business performance
8.2. BAXTER INTERNATIONAL, INC.
8.2.1. Company overview
8.2.2. Corporate snapshot
8.2.3. Operational business areas
8.2.4. Product portfolio
8.2.5. Business performance
8.2.6. Important strategic steps and developments
8.3. B. BRAUN MELSUNGEN AG
8.3.1. Company overview
8.3.2. Corporate snapshot
8.3.3. Operational business areas
8.3.4. Product portfolio
8.3.5. Business performance
8.3.6. Important strategic steps and developments
8.4. DANONE SA
8.4.1. Company overview
8.4.2. Corporate snapshot
8.4.3. Operational business areas
8.4.4. Product portfolio
8.4.5. Business performance
8.4.6. Important strategic steps and developments
8.5. FRESENIUS KABI AKTIENGESELLSCHAFT
8.5.1. Company overview
8.5.2. Corporate snapshot
8.5.3. Operational business areas
8.5.4. Product portfolio
8.5.5. Business performance
8.5.6. Important strategic steps and developments
8.6. HORMEL FOODS CORPORATION
8.6.1. Company overview
8.6.2. Corporate snapshot
8.6.3. Operational business areas
8.6.4. Product portfolio
8.6.5. Business performance
8.7. MEIJI HOLDINGS CO., LTD.
8.7.1. Company overview
8.7.2. Operational business areas
8.7.3. Product portfolio
8.7.4. Business performance
8.7.5. Important strategic steps and developments
8.8. NESTLE SA
8.8.1. Company overview
8.8.2. Corporate snapshot
8.8.3. Operational business areas
8.8.4. Product portfolio
8.8.5. Business performance
8.8.6. Important strategic steps and developments
8.9. RECKITT BENCKISER GROUP PLC
8.9.1. Company overview
8.9.2. Corporate snapshot
8.9.3. Operational business areas
8.9.4. Product portfolio
8.9.5. Business performance
8.9.6. Important strategic steps and developments
8.10. FOOD INC
8.10.1. Company overview
8.10.2. Corporate snapshot
8.10.3. Operational business areas
8.10.4. Product portfolio
8.10.6. Important strategic steps and developments

Please visit https://www.researchandmarkets.com/r/rktsuy for more information on this report

Media contact:

Research and Markets
Laura wood, Senior manager
[email protected]

For EST office hours, call + 1-917-300-0470. at
For US / CAN toll free call + 1-800-526-8630
For GMT office hours, call + 353-1-416-8900. at

US Fax: 646-607-1904
Fax (outside the US): + 353-1-481-1716

SOURCE Research and Markets

similar links

http://www.researchandmarkets.com